Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2019-07-04 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
第二届监事会第八次会议（临时）决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of a company regarding the approval of proposals related to a 2019 restricted stock incentive plan. It details the meeting date, attendance, voting results, and legal compliance of the proposals. The document does not contain financial statements or detailed financial data but rather reports on internal governance decisions and approvals. It is not an annual report, audit report, earnings release, or any financial report. It is also not a proxy solicitation or voting results announcement. The content fits best under Board/Management Information (MANG) as it relates to internal governance and supervisory board decisions on management incentive plans.
2019-07-04 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of idle raised funds for cash management and the maturity redemption of related financial products. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, details board and shareholder approvals, and provides specifics on the investment and its returns. The document is relatively short (1488 characters) and primarily serves to inform shareholders and the public about the company's cash management activities and the maturity of these investments. It does not contain comprehensive financial statements or detailed financial performance data. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is also not a report publication announcement since it contains substantive information about the cash management activity itself. The content fits best under Capital/Financing Update (CAP), as it relates to the company's management of raised funds and financial investments thereof.
2019-06-28 Chinese
大股东减持股份预披露公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a major shareholder's plan to reduce their shareholding in the company. It details the shareholder's identity, the number and percentage of shares to be reduced, the methods and timing of the reduction, and compliance with relevant regulations. There is no financial data, earnings information, or management discussion. The document is a notification of a significant shareholding change, specifically a pre-disclosure of a planned reduction in shares by a shareholder holding more than 5%. This fits the definition of a Major Shareholding Notification (MRQ). The document length is 2531 characters, which is typical for such announcements and not a full report or regulatory filing. Therefore, the correct classification is MRQ with high confidence.
2019-06-27 Chinese
关于使用自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress of using its own funds for cash management, specifically investing in financial products. It details the amounts, dates, risk assessments, and compliance with regulatory requirements. The document references regulatory guidelines and previous board and shareholder approvals. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a report publication announcement since it contains substantive information about the investment activities and risk management. The content fits best with a Capital/Financing Update as it relates to the company's use of funds and investment activities.
2019-06-21 Chinese
股东减持股份预披露公告
Transaction in Own Shares Classification · 100% confidence The document is a shareholder pre-disclosure announcement regarding a planned reduction in shareholding by a specific shareholder, Jin Xiaoping, including details about the number of shares, reasons for reduction, and compliance with regulatory requirements. It does not contain financial statements, earnings data, or management discussion. It is a regulatory announcement about a shareholder's planned transaction in their own shares. Therefore, it fits the category of Transaction in Own Shares (POS). The document length is short and focused on the share reduction plan, not a full report or earnings release.
2019-06-20 Chinese
股东减持股份预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a shareholder pre-disclosure announcement regarding a planned reduction in shareholding by a significant shareholder (西藏嘉泽创业投资有限公司) of the company 易明医药. It details the number of shares to be reduced, the methods of reduction, the timeline, and compliance with relevant securities laws and regulations. There is no financial data, earnings information, or management discussion. The document is a formal announcement about a shareholder's planned sale of shares, which fits the category of a Major Shareholding Notification (MRQ). The document length is short (1812 characters), and it is not a report or a certification but a regulatory announcement about shareholding changes.
2019-06-18 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.